How the GLP-1 Era is driving a Paradigm Shift in Food Industry Growth
The STEP program a series of studies on semaglutide for weight loss showed consistent weight loss across all patient demographics
The injection is approved by the FDA and is given by injection under the guidance of an iCRYO nurse
Furthermore, alongside the increasing prevalence of related cardiometabolic diseases such as diabetes, obesity and chronic kidney disease (CKD), the number of people with HF has increased to around 64 million globally, amongst whom most are also living with type 2 diabetes or obesity ( Within the past 2 decades, glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have emerged as effective agents to improve glycaemic control in type 2 diabetes and to reduce body weight in people with overweight or obesity (Mller et al., 2019
While the bedtime dose is the standard "anti-aging" and recovery protocol, a morning dose can be effective for: Fat Loss: Taking it upon waking in a fasted state can help mobilize fat stores for energy throughout the day
An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus